Zubsolv
Loading...Zubsolv Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Severe hypersensitivity reactions (including bronchospasm, laryngospasm and cardiovascular collapse) have been reported which are possibly related to local anesthesia from sucking or chewing the capsule instead of swallowing it. Severe reactions have required intervention with vasopressor agents and supportive measures.
Isolated instances of bizarre behavior, including mental confusion and visual hallucinations, have also been reported in patients taking benzonatate in combination with other prescribed drugs.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Benzonatate is indicated for the symptomatic relief of cough.
History
There is currently no drug history available for this drug.
Other Information
Benzonatate, a non-narcotic oral antitussive agent, is 2, 5, 8, 11, 14, 17, 20, 23, 26-nonaoxaoctacosan-28-yl p-(butylamino) benzoate; with a molecular weight of 603.7.
Each soft gelatin capsule, for oral administration, contains 100 mg or 200 mg of benzonatate USP.
Benzonatate Capsules, USP also contain the following inactive ingredients: D&C Yellow # 10, gelatin, glycerin, purified water, methylparaben, propylparaben and titanium dioxide.
Sources
Zubsolv Manufacturers
-
Orexo Us, Inc.
![Zubsolv (Buprenorphine Hydrochloride And Naloxone Hydrochloride) Tablet, Orally Disintegrating [Orexo Us, Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Zubsolv | Golden State Medical Supply, Inc.
Adults and Children over 10 years of age: Usual dose is one 100 mg or 200 mg capsule t.i.d. as required. If necessary, up to 600 mg daily may be given.
Login To Your Free Account